day trading oct 8 morning , page-74

yes Pewal back testing on low volume.

another bio, that has started to recover well (like AVX), however unlike AVX, have formally signed a joint venture heads of agreement with Vaxine Ltd is BXN.

close to closing 1st gap at 3.6c. shareholder meeting end of this month on vote, proving very interesting.

BBG, showing a little more ticker today in the right direction - Day 4 since market update/asx query re AFR leaky article. also annc today on new board appointment, seems to be a very good candidate based on his previous employment history.